10mg vial only $99
3rd-Party Tested Over 99% Purity
Low price guarantee!

Note: This article is for educational and informational purposes only. Any studies referenced relate solely to laboratory and scientific models. All peptides from NRG BioLabs are for Research Use Only. They are not approved drugs, supplements, topical products, or cosmetic products and are not for human or veterinary use.

Names like Semaglutide, Tirzepatide and Retatrutide can feel confusing if you’re new to metabolic research. Many people hear terms like “GLP-1” or “GLP-2” and assume they’re too scientific to understand. At NRG Biolabs, LLC, our goal is to make this world simple, clear and accessible, even for beginners.

This guide explains what GLP molecules are, how their roles differ, where Semaglutide, Tirzepatide and Retatrutide fit in, and why research-grade peptides and FDA-approved medications are not the same. Everything here is written to help the average person understand the basics before we move into the more detailed scientific information.

The Difference Between GLP-1, GLP-2 and GLP-3-Type Compounds in Plain Language

Before diving into deeper science, here’s the simplest way to think about GLP-1, GLP-2 and GLP-3 type compounds. Imagine your body as a large building with different systems that need maintenance. Each GLP works on a different part of that building.

• GLP-1 compounds (like Semaglutide)
  These influence appetite and blood sugar. Think of GLP-1 as the part of your building that manages energy flow. It’s the system that tells you when you’ve had enough food and helps your body use sugar more effectively.
• GLP-2 compounds and dual incretin compounds (like Tirzepatide)
  GLP-2 helps with gut support, while dual agonists like Tirzepatide activate GLP-1 and GIP together. These help with the building’s internal structure and efficiency. They support digestion, nutrient processing and broader metabolic signals.
• GLP-3-type or triple agonist compounds (like Retatrutide)
  These hit three metabolic pathways instead of one or two. If GLP-1 is a basic tool and dual agonists are two-in-one tools, triple agonists are multitools with multiple powerful functions at once. They deliver broader metabolic signals across several systems.

To remember the differences quickly:

• GLP-1 helps manage hunger
• GLP-2 supports the gut and nutrient processing
• Dual and triple agonists activate multiple metabolic pathways at the same time

Now that you have the big picture, let’s get into the more detailed science behind these compounds.

What “GLP” Actually Means

GLP stands for Glucagon-Like Peptide, a family of messenger molecules your body naturally uses to help regulate appetite, blood sugar, digestion and nutrient absorption. A helpful way to imagine them is to picture your body as a busy city. GLP messengers deliver instructions to organs involved in processing food and managing energy.

These messages influence:

• • Fullness cues sent to the brain
  • Insulin release from the pancreas
  • How quickly the stomach empties
  • Gut lining repair and nutrient absorption

Each GLP type communicates through different “routes,” which is why GLP-1, GLP-2 and GLP-3-type compounds produce different effects.

GLP-1: Appetite and Blood Sugar Signaling (Semaglutide)

GLP-1 is the most widely recognized member of this group. When you eat, GLP-1 helps signal that appetite can slow down. It works with the pancreas to support insulin release and slows down how quickly food leaves the stomach. These actions help smooth out post-meal blood sugar levels and influence feelings of fullness.

Semaglutide is a GLP-1 receptor agonist created to mimic this natural activity. In its FDA-approved medication form, it is used for type 2 diabetes management and chronic weight care in certain adults. Research-grade Semaglutide, however, is not an approved medication and is used only for controlled laboratory experiments.

Key roles of GLP-1 include:

• • Fullness signaling
  • Support for insulin release
  • Slower stomach emptying

GLP-2: Gut Repair and Digestive Support (and Where Tirzepatide Fits)

GLP-2 has a different job entirely. It concentrates on the digestive system, where it helps maintain the intestinal lining, strengthen the gut barrier and support nutrient absorption. For this reason, GLP-2 is often described as a “contractor” that keeps the structure of the gut strong.

Research on GLP-2 often focuses on:

• • Supporting the intestinal lining
  • Improving nutrient absorption
  • Helping with gut repair and maintenance

Tirzepatide frequently enters GLP conversations but is not a GLP-2 compound. Instead, it activates:

• • GLP-1 receptors
  • GIP receptors

This combination makes it a dual incretin agonist, giving it broader metabolic activity than GLP-1 alone. In its FDA-approved forms, tirzepatide is used for type 2 diabetes and, depending on the product label, chronic weight management.

Research-grade Tirzepatide, like all NRG Biolabs products, is intended for laboratory research only.

GLP-3-Type / Triple Agonists: Retatrutide and the Next Generation

There is no natural hormone called GLP-3, but researchers use the term informally when referring to compounds that activate three metabolic pathways at once. Retatrutide is the most widely studied example of this category.

It activates:

• • GLP-1 receptors
  • GIP receptors
  • Glucagon receptors

Because it delivers three different metabolic messages simultaneously, Retatrutide is often compared to a multitool. Early clinical research explores how these combined signals might influence appetite, blood sugar regulation and energy expenditure. Retatrutide is still in trials and is not widely available as an approved medication.

A Simple Comparison of GLP Peptides

Here’s the easiest way to understand GLP-1 vs GLP-2 vs GLP3:

• GLP-1 compounds (Semaglutide) activate one primary metabolic pathway.
• Dual incretin compounds (Tirzepatide) activate two pathways for broader metabolic signaling.
• Triple agonists (Retatrutide) activate three pathways at once and represent an emerging area of research.

This progression shows why scientists are increasingly studying dual and triple agonists.

Research Peptides vs Prescription Medications

A critical distinction must be made between research peptides and FDA-approved medications. Approved medications are manufactured under strict quality guidelines, tested in clinical trials and prescribed by licensed medical providers for specific uses.

Research peptides:

• Are for laboratory research only
• Are not approved as drugs, supplements or consumable products
• Are used to study receptor function, cell signaling and metabolic pathways

NRG Biolabs operates exclusively within the research-only category.